Clinical Trials Directory

Trials / Sponsors / Rakuten Medical, Inc.

Rakuten Medical, Inc.

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregion
Recurrent Head and Neck Squamous Cell Carcinoma
Phase 32024-12-24
TerminatedASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Recurrent Head and Neck Cancer, With
Head and Neck Cancer
Phase 22022-04-19
WithdrawnRM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and
Cutaneous Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
Phase 12022-03-24
Active Not RecruitingASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer
Head and Neck Cancer, Squamous Cell Carcinoma of Head and Neck
Phase 22022-01-21
Active Not RecruitingAn Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing
Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma, Locally Advanced Cutaneous Squamous Cell Carcinoma
Phase 1 / Phase 22020-12-21
Active Not RecruitingASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Tw
Head and Neck Cancer
Phase 32019-05-09
CompletedStudy of RM-1929 and Photoimmunotherapy in Patients With Recurrent Head and Neck Cancer
Recurrent Head and Neck Cancer
Phase 1 / Phase 22015-06-01